Fecal Transplant Treatments Could Transmit Monkeypox, FDA Warns
WEDNESDAY, Aug. 24, 2022 (HealthDay News) -- Fecal microbiota for transplantation (FMT) treatments could infect patients with monkeypox, the U.S. Food and Drug Administration has warned.
Since May, an outbreak of monkeypox has been spreading in multiple countries, including the United States. Nearly 16,000 people in the United States have already been infected with the virus, which is transmitted through close physical contact with symptomatic individuals.
Monkeypox virus DNA has been found in rectal swabs and stool samples from infected people, the FDA said in its alert, which was issued this week. That includes one study where monkeypox virus was found in three people who reported no symptoms of the disease, the agency said.
"FDA is advising that clinical use of FMT has the potential to transmit monkeypox virus," the alert said. As a result, the FDA has recommended donor screening for clinical trials involving fecal transplants if the studies involve stool donated on or after March 15, 2022. Patients should also be informed of the monkeypox risk, the agency added.
Related Posts
Nexletol Could Be Alternative Cholesterol Med for Folks Who Can’t Take Statins
MONDAY, March 6, 2023 (HealthDay News) -- Not everyone can tolerate statins to...
Biden Administration to Invest $100 Million to Ease Health Worker Shortage
FRIDAY, Oct. 15, 2021 (HealthDay News) -- The National Health Service Corps will...
¿Puede pararse en una pierna por 10 segundos? Quizá viva más tiempo
MIÉRCOLES, 22 de junio de 2022 (HealthDay News) -- Parece fácil, pero pararse en...
Alzheimer Disease in Down Syndrome Similar to Autosomal Dominant Form
WEDNESDAY, May 25, 2022 (HealthDay News) -- Variability of age at symptom onset...